Rothschild Investment LLC’s Enliven Therapeutics ELVN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$903	Hold	45	–	–	﹤0.01%	2526
2025 Q1	$886	Buy	45 +5	+13%	+$98	﹤0.01%	2407
2024 Q4	$900	Buy	40 +5	+14%	+$113	﹤0.01%	2273
2024 Q3	$894	Buy	35 +30	+600%	+$766	﹤0.01%	2249
2024 Q2	$117	Buy	+5	New	+$117	﹤0.01%	2689